期刊文献+

伊曲康唑注射液无菌检查方法研究 被引量:4

Study on Sterility Test of Intraconacole Injection
下载PDF
导出
摘要 目的建立伊曲康唑注射液的无菌检查方法。方法采用薄膜过滤法,每管接种量50mL,用pH=7.0的氯化钠-蛋白胨缓冲液500mL冲洗,对伊曲康唑注射液进行无菌检查。结果用400mL的pH=7.0的氯化钠-蛋白胨缓冲液冲洗,可消除该药对金黄色葡萄球菌、铜绿假单胞菌、大肠埃希菌、枯草芽孢杆菌和生孢梭菌的抗菌作用,用500mL冲洗可消除其对黑曲霉菌和白色念珠菌的抗菌作用。该药对真菌的抗菌作用比对细菌的抗菌作用更强。结论所建立的方法简便、准确、可靠、重现性好。 Objective To establish a sterility test of Intraconacole Injection. Methods To perform the sterility test by the membrane filtration method. To inoculate 50 mL sample solution into each tube and rinse the filter membrane by 500 mL pH7, 0 sodium chloridepeptone buffer solution. Results It could remove the antibacterial activity to Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Bacillus subtilis and Clostridium sporogenes by rinsing the filter membrane in 400 mL pH7.0 sodium chloride- peptone buffer solution, but it needed 500 mL to Aspergillus niger and Candida albieans. The antibacterial activity of Intraconaeole Injection to fungus was stronger than to bacteria. Conclusion The method established is convenient, accurate and reliable with good reproducibility.
出处 《中国药业》 CAS 2009年第3期20-21,共2页 China Pharmaceuticals
关键词 伊曲康唑注射液 无菌检查 抗菌作用 薄膜过滤法 Intraconacole Injection sterility test antibacterial activity membrane filtration method
  • 相关文献

参考文献3

二级参考文献25

  • 1黄晓军.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2005,44(7):554-556. 被引量:423
  • 2Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000[J ]. N Engl J Med, 2003 ; 348 : 1546.
  • 3Kontoyiannis DP, Lewis RE. Antifungal drug resistance of pathogenic fungi[J ]. Lancet, 2002,359:1135.
  • 4Potter M. European experience with oral solution and intravenous itraconazole[ J ]. Oncology ,2001,15( 11 Suppl 9) :27.
  • 5Boogaerts M, Winston DJ, Bow EJ, et al. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy[J ]. Ann Intern Med,2001 ; 135:412.
  • 6Physicians' Desk Reference (PDR) (54th ed)[M]. Medical Economics Company-Thomson Healtheare, 2000:1460-- 1462.
  • 7Parfitt K. Martindale The complete drug reference [ M].32nd ed. Pharmaceutical press, 1999;381.
  • 8De Beule K, Van Gestel J. Pharmacology of itraconazole [ J ].Drugs ,2001,61(Suppl 1) :27.
  • 9Caillot D, Bassaris H, Seifert WF, et al. Efficacy, safety and pharmacokinetics of intravenous followed by oral itraconazole in patients with invasive pulmonary aspergillosis [ J ]. Antimicrob Agents Chemother , 1999,9:26.
  • 10Estey E. Reducing mortality associated with immediate treatment complications of adult leukemias[ J ]. Semin-Hemato1,2001,38(4Suppl 10) :32.

共引文献11

同被引文献24

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部